Vestnik dermatologii i venerologiiVestnik dermatologii i venerologii0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov111810.25208/vdv1118Research ArticleСutaneous Vasculitis: Classification, Diagnosis and Differential Diagnosis (Part 2)KhairutdinovVladislav R.<p>Dr. Sci. (Med.)., Assoc. Prof., Assoc. Prof. of the Department of Skin and Sexually Transmitted Diseases</p>haric03@list.ruhttps://orcid.org/0000-0002-0387-5481BelousovaIrena E.<p>Dr. Sci. (Med.)., Assoc. Prof., Prof. of the Department of Skin and Sexually Transmitted Diseases</p>irena.belousova@mail.ruSamtsovAleksey V.<p>Dr. Sci. (Med.)., Prof., Head of the Department of Skin and Sexually Transmitted Diseases</p>avsamtsov@mail.ruFederal state budgetary educational institution of higher military education “Military Medical Academy named after S.M. Kirov” of the Russian Ministry of Defense0208202096214230904202012052020Copyright © 2020, Khairutdinov V.R., Belousova I.E., Samtsov A.V.2020<p style="text-align: justify;">This article is a continuation of the literature review on skin vasculitis. In the first part, information was presented on the current nomenclature and prevalence of vasculitis, pathomorphological changes in the skin, as well as diagnostic algorithms for examining patients with this pathology are reflected.</p>
<p style="text-align: justify;">The second part of the article contains a detailed description of the elements of the skin rash with systemic and organ-specific vasculitis, presents the clinical manifestations observed with damage to other organs and systems, the development of possible complications.</p>
<p style="text-align: justify;">The data on modern treatment tactics are summarized, modern approaches using pathogenetic and symptomatic therapy of patients with various vasculitis are reflected.</p>skin vasculitisleukocytoclastic vasculitistreatment of vasculitisShenlein — Genoch diseaseerythema elevatum diutinumurticarial vasculitisBehcet’s diseaseваскулиты кожилейкоцитокластический васкулитлечение васкулитовболезни Шенлейна — Генохаэритема возвышающаяся стойкаяуртикарный васкулитболезнь Бехчета[Sunderkötter C.H., Zelger B., Chen K.R. et al. Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2018 Feb; 70 (2): 171—184.][Sunderkötter C., Michl C. Cutaneous alterations in vasculitides: Part 1: Nomenclature, classification and correlation between clinical signs and histological features. Internist (Berl). 2019; Aug; 60 (8): 799—804.][Kluger N., Pagnoux C., Guillevin L., Frances C. Comparison of cutaneous manifestations in systemic polyarteritis nodosa and microscopic polyangiitis. Br J Dermatol 2008; 159: 615—620.][Criado P.R., Marques G.F., Morita T.C., de Carvalho J.F. Epidemiological, clinical and laboratory profiles of cutaneous polyarteritis nodosa patients: report of 22 cases and literature review. Autoimmun. Rev. 2016; 15: 558—563.][Newell E.L., Mallipeddi R., Murdoch M.E. et al. A case of cutaneous extravascular necrotizing granuloma without systemic manifestations. Clin. Exp. Dermatol. 2007; 32: 509—512.][Cabral D.A., Morishita, K. Antineutrophil Cytoplasmic Antibody Associated Vasculitis. Textbook of Pediatric Rheumatology, 2016; 484—499.][Ramos-Casals M., Stone J.H., Cid M.C., Bosch X. The cryoglobulinaemias. Lancet. 2012; 379: 348—360.][Terrier B., Karras A., Kahn J.E. et al. The spectrum of type I cryoglobulinemia vasculitis: newinsights based on 64 cases. Medicine (Baltimore). 2013; 92: 61—68.][Gonzalez L.M., Krysicka Janniger C., Schwartz R.A. Pediatric Henoch Schonlein purpura. Internat. J. Dermatol. 2009; 48 (11): 1157—1165.][Langford C.A. Vasculitis. J. Allergy Colin. Immunol. 2010; 125: 216—225.][Rigante D., Castellazzi L., Bosco A. et al. Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura? Autoimmun. Rev. 2013; 12 (10): 1016—1021.][Arora A., Wetter D.A., Gonzalez-Santiago T.M., Davis M.D., Lohse C.M. Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County. Minnesota. Mayo Clin. Proc. 2014; 89: 1515—1524.][Hetland L.E., Susrud K.S., Lindahl K.H., Bygum A. Henoch-Schönlein Purpura: A Literature Review. Acta Derm. Venereol. 2017; 15; 97 (10): 1160—1166.][Batu E.D., Sarı A., Erden A. et al. Comparing immunoglobulin A vasculitis (Henoch-Schönlein purpura) in children and adults: a single-centre study from Turkey. Scand. J. Rheumatol. 2018; 47 (6): 481—486.][Davis M.D., Daoud M.S., Kirby B., Gibson L.E., Rogers R.S. III. Clinicopathologic correlation of hypocomplementemic and normo-complementemic urticarial vasculitis. J. Am. Acad. Dermatol. 1998; 38: 899—905.][Loricera J., Calvo-Rio V., Mata C. et al. Urticarial vasculitis in northern Spain: clinical study of 21 cases. Medicine (Baltimore). 2014; 93: 53—60.][Broekaert S.M., Boer-Auer A., Kerl K. et al. Neutrophilic epitheliotropism is a histopathological clue to neutrophilic urticarial dermatosis. Am. J. Dermatopathol. 2016; 38: 39—49.][Kolkhir P., Grakhova M., Bonnekoh H., Krause K., Maurer M. Treatment of urticarial vasculitis: A systematic review. J. Allergy Clin. Immunol. 2019; 143 (2): 458—466.][Kim B., LeBoit P.E. Histopathologic features of erythema nodosum–like lesions in Behcet disease: a comparison with erythema nodosum focusing on the role of vasculitis. Am. J. Dermatopathol. 2000; 22: 379—390.][Hamuryudan V., Hatemi G., Tascilar K. et al. Prognosis of Behcet’s syndrome among men with muco-cutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial. Rheumatology (Oxford). 2010; 49: 173—177.][Ugurlu N., Bozkurt S., Bacanli A., Akman-Karakas A., Uzun S., Alpsoy E. The natural course and factors affecting severity of Behcet’s disease: a single-center cohort of 368 patients. Rheum. Int. 2015; 35: 2103—2107.][Jennette J.C., Falk R.J., Bacon P.A. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013; 65: 1—11.][Pozdnyakova O., Garg A., Mahalingam M. Nodular vasculitis — a novel cutaneous manifestation of autoimmune colitis. J. Cutan. Pathol. 2008; 35 (3): 315—319.][Ziemer M., Koehler M.J., Weyers W. Erythema elevatum diutinum — a chronic leukocytoclastic vasculitis microscopically indistinguishable from granuloma faciale? J. Cutan. Pathol. 2011; 38 (11): 876—883.][Ba W., Yang Y., Zheng L. et al. Erythema elevatum diutinum with pustule formation: An unusual finding. J. Cutan. Pathol. 2018; 45 (3): 246—248.][Mahr A., Batteux F., Tubiana S. et al. Prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Arthritis Rheum. 2014; 66: 1672—1677.][Kelly R.I., Opie J., Nixon R. Golfer’s vasculitis. Australas J. Dermatol. 2005; 46: 11—14.][Micheletti R.G., Werth V.P. Small Vessel Vasculitis of the Skin. Rheum. Dis. Clin. North America. 2015; 41 (1): 21—32.][Yates M., Watts R.A., Bajema I.M. et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann. Rheum. Dis. 2016; 75 (9): 1583—1594.][Calich A.L., Puechal X., Pugnet G. et al. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients. J. Autoimmun. 2014; 50: 135—141.][Charles P., Neel A., Tieulie N. et al. Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Rheum. (Oxford). 2014; 53 (3): 532—539.][Thai L.H., Charles P., Resche-Rigon M., Desseaux K., Guillevin L. Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients. Autoimmun. Rev. 2014; 13 (3): 313—318.][Bech A.P., Reichert L.J., Cohen Tervaert J.W. Dapsone for the treatment of chronic IgA vasculitis (Henoch-Schonlein). Neth. J. Med. 2013; 71: 220—221.][Momen S.E., Jorizzo J., Al-Niaimi F. Erythema elevatum diutinum: a review of presentation and treatment. J. Eur. Acad. Dermatol. Venereol. 2014; 28 (12): 1594—1602.][Alquorain N.A.A., Aljabr A.S.H., Alghamdi N.J. Cutaneous Polyarteritis Nodosa Treated with Pentoxifylline and Clobetasol Propionate: A Case Report. Saudi J. Med. Sci. 2018; 6 (2): 104—107.][Tosoni C., Lodi-Rizzini F., Cinquini M. et al. A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: a retrospective study of 47 patients. Clin. Exp. Dermatol. 2009; 34: 166—170.][Dudley J., Smith G., Llewelyn-Edwards A. et al. Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein purpura (HSP). Arch. Dis. Child. 2013; 98: 756—763.][Jauhola O., Ronkainen J., Autio-Harmainen H. et al. Cyclosporine A vs. methylprednisolone for Henoch-Schonlein nephritis: a randomized trial. Pediatr. Nephrol. 2011; 26: 2159—2166.][Goeser M.R., Laniosz V., Wetter D.A. A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis. Am. J. Clin. Dermatol. 2014; 15 (4): 299—306.][Bellan M., Pirisi M., Sainaghi P.P. Long-term remission of corticosteroid- and cyclophosphamide-resistant Henoch-Schönlein purpura with rituximab. Scand. J. Rheum. 2016; 45 (1): 83—84.][Ramos-Casals M., Nardi N., Lagrutta M. et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore). 2006; 85: 95—104.]